Login
$RARE
$15.85 -$0.05 (0.31%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Emil D. Kakkis Also a director
President and Chief Executive Officer, Director
65 Not stated Not stated $11,405,535
Howard Horn
Chief Financial Officer, Corporate Strategy and Executive Vice President
48 Since 2023
3 years
Not stated $3,750,607
Eric Crombez
Chief Medical Officer and Executive Vice President
53 Since 2023
3 years
2017 $4,002,173
Erik Harris
Chief Commercial Officer and Executive Vice President
56 Since 2019
7 years
Not stated $4,045,072
Karah Parschauer
Chief Legal Officer & Corporate Affairs and Executive Vice President
48 Since 2023
3 years
Not stated $3,509,313
Theodore Alan Huizenga
SVP, Chief Accounting Officer
Title from the Form 4 dated Sep 15, 2026
Not stated Not stated Not stated Not reported
Dennis Huang
See Remarks
Title from the Form 4 dated Apr 16, 2026
61 Not stated Not stated Not reported
John R. Pinion II
See Remarks
Title from the Form 4 dated Apr 16, 2026
59 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
9.4 years
from year joined
CEO also chairs the board
No
Daniel G. Welch
Director Age On board Independent Other public boards 2025 pay Source
Daniel G. Welch
68 2015
11 years
Independent Structure Therapeutics, Inc., Prothena Corporation plc $508,541
Emil D. Kakkis
65 2010
16 years
Not independent None stated Paid as CEO
Shehnaaz Suliman
54 2019
7 years
Independent 10X Genomics, Inc. $478,291
Deborah Dunsire, M.D.
63 2017
9 years
Independent McKesson Corporation $475,041
Michael Narachi
66 2015
11 years
Independent None stated $490,041
Corsee D. Sanders, Ph.D.
69 2021
5 years
Independent BeOne Medicines, Legend Biotech Corporation $477,541
Matthew K. Fust
61 2014
12 years
Independent Atara Biotherapeutics, Inc., Crinetics Pharmaceuticals, Inc., Neumora Therapeutics Inc. $488,541
Amrit Ray, M.D.
53 2022
4 years
Independent Fortrea Holdings Inc. $472,541

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 27, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support